Global

Medicine Experts

Sudhesh Kumar

professor
School of Medicine
The University of Warwick
United Kingdom

Biography

Professor Sudhesh Kumar is Dean of the Warwick Medical School and Director of the Institute of Digital Healthcare at University of Warwick. In addition to these roles, he is also a member of the Coventry & Rugby Health and Wellbeing Board, and the Medical Schools Council. He is a clinical endocrinologist by background with 22 years experience as a Consultant Physician in the NHS. His research interest is obesity and its complications, particularly Type 2 diabetes. His interests include developing novel approaches to managing obesity and diabetes that has helped to transform and improve patient care and treatment. He has published over 240 papers and 6 books on these subjects.

Research Interest

1. Pathogenesis of obesity driven diabetes and the metabolic syndrome. My group uses multi-method approaches that integrates clinical and laboratory-based studies to elucidate the molecular basis of obesity-driven diabetes and aims to determine the molecular basis of the link between adiposity and its metabolic and cardiovascular complications. 2. The molecular basis of obesity and body fat distribution, investigating control of energy metabolism and factors regulating the distribution of body fat in different adipose tissue depots. 3. Novel approaches to the treatment of obesity and type 2 diabetes incorporating new behavioural, dietary and pharmacological approaches, including early intervention to prevent type 2 diabetes.

Publications

  • Reddy NL, Peng C, Carreira MC, Halder L, Hattersley J, Piya MK, Tripathi G, Randeva HS, Casanueva FF, McTernan PG, Kumar S. Enhanced thermic effect of food, postprandial NEFA suppression and raised adiponectin in obese women who eat slowly. Clinical endocrinology. 2015 Jun 1;82(6):831-7.

  • Montvida O, Klein K, Kumar S, Khunti K, Paul SK. Addition of or switch to insulin therapy in people treated with glucagon‐like peptide‐1 receptor agonists: A real‐world study in 66 583 patients. Diabetes, Obesity and Metabolism. 2017 Jan 1;19(1):108-17.

  • Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Raskin P, Zacho J, Andersen TH, Philis‐Tsimikas A. Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial (BEGIN: ADD TO GLP‐1 Study). Diabetes, Obesity and Metabolism. 2016 Jul 1;18(7):663-70.

Global Experts from United Kingdom

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America